Patrick Harris
Patrick Harris
University of Queensland Centre for Clinical Research
Verified email at - Homepage
Cited by
Cited by
Antimicrobial resistance in ESKAPE pathogens
DMP De Oliveira, BM Forde, TJ Kidd, PNA Harris, MA Schembri, ...
Clinical microbiology reviews 33 (3), 10.1128/cmr. 00181-19, 2020
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
Jama 320 (10), 984-994, 2018
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
HM Zowawi, PNA Harris, MJ Roberts, PA Tambyah, MA Schembri, ...
Nature Reviews Urology 12 (10), 570-584, 2015
β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few …
PNA Harris, PA Tambyah, DL Paterson
The Lancet Infectious Diseases 15 (4), 475-485, 2015
Colistin resistance: a major breach in our last line of defence
DL Paterson, PNA Harris
The Lancet Infectious Diseases 16 (2), 132-133, 2016
Health risks of flood disasters
DL Paterson, H Wright, PNA Harris
Clinical Infectious Diseases 67 (9), 1450-1454, 2018
Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
TM Ng, WX Khong, PNA Harris, PP De, A Chow, PA Tambyah, DC Lye
PloS one 11 (4), e0153696, 2016
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
PNA Harris, JK Ferguson
International journal of antimicrobial agents 40 (4), 297-305, 2012
Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches
MJ Roberts, HY Bennett, PN Harris, M Holmes, J Grummet, K Naber, ...
Urology 104, 11-21, 2017
Treatment of infections by OXA-48-producing Enterobacteriaceae
A Stewart, P Harris, A Henderson, D Paterson
Antimicrobial agents and chemotherapy 62 (11), 10.1128/aac. 01195-18, 2018
Achromobacter Infections and Treatment Options
B Isler, TJ Kidd, AG Stewart, P Harris, DL Paterson
Antimicrobial agents and chemotherapy 64 (11), 10.1128/aac. 01025-20, 2020
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis
E Righi, AM Peri, PNA Harris, AM Wailan, M Liborio, SW Lane, ...
Journal of Antimicrobial Chemotherapy 72 (3), 668-677, 2017
Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study
A Henderson, DL Paterson, MD Chatfield, PA Tambyah, DC Lye, PP De, ...
Clinical Infectious Diseases 73 (11), e3842-e3850, 2021
Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
D Koulenti, A Song, A Ellingboe, MH Abdul-Aziz, P Harris, E Gavey, ...
International journal of antimicrobial agents 53 (3), 211-224, 2019
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic …
PNA Harris, JY Wei, AW Shen, AA Abdile, S Paynter, RR Huxley, ...
Journal of Antimicrobial Chemotherapy 71 (2), 296-306, 2016
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp …
PNA Harris, AY Peleg, J Iredell, PR Ingram, S Miyakis, AJ Stewardson, ...
Trials 16, 1-8, 2015
Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia …
PNA Harris, M Yin, R Jureen, J Chew, J Ali, S Paynter, DL Paterson, ...
Antimicrobial resistance and infection control 4, 1-10, 2015
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
PNA Harris, JF McNamara, DC Lye, JS Davis, L Bernard, AC Cheng, ...
Clinical microbiology and infection 23 (8), 533-541, 2017
Long-term morbidity and mortality following bloodstream infection: a systematic literature review
JF McNamara, E Righi, H Wright, GF Hartel, PNA Harris, DL Paterson
Journal of Infection 77 (1), 1-8, 2018
MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Effect of piperacillin-tazobactam vs meropenem on 30-day …
PNA Harris, PA Tambyah, DC Lye
The system can't perform the operation now. Try again later.
Articles 1–20